How is the regulatory landscape shaping drug development?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Robert Albarano and Kristina Capiak from Arthur D Little, who have experience maximising commercial success of drug discovery portfolios and securing FDA designations. Bruno spoke to Robert and Kristina about the challenges of the regulatory landscape, the global implications of faster FDA approvals, and whether personalised medicines are set to become a key area for investment. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.